-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, CcrG1Cc5hIqQTZb0j5exgSZs66N7exj/7hil2sDFxxDD9d30s2CNvvVLj/JGApBV SYGYtLtVtlD9ucnD/Ccoxg== 0000950137-07-001047.txt : 20070129 0000950137-07-001047.hdr.sgml : 20070129 20070129120652 ACCESSION NUMBER: 0000950137-07-001047 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20070125 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20070129 DATE AS OF CHANGE: 20070129 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ATS MEDICAL INC CENTRAL INDEX KEY: 0000824068 STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842] IRS NUMBER: 411595629 STATE OF INCORPORATION: MN FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-18602 FILM NUMBER: 07559555 BUSINESS ADDRESS: STREET 1: 3905 ANNAPOLIS LA STREET 2: SUITE 105 CITY: MINNEAPOLIS STATE: MN ZIP: 55447 BUSINESS PHONE: 6125537736 MAIL ADDRESS: STREET 1: 3905 ANNAPOLIS LANE STREET 2: SUITE 105 CITY: MINNEAPOLIS STATE: MN ZIP: 55447 FORMER COMPANY: FORMER CONFORMED NAME: ATS MEDCIAL INC DATE OF NAME CHANGE: 19920803 8-K 1 c11781e8vk.txt CURRENT REPORT ================================================================================ UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 DATE OF REPORT: JANUARY 25, 2007 (date of earliest event reported) ATS MEDICAL, INC. (Exact name of registrant as specified in its charter) Commission File Number: 0-18602 ---------- MINNESOTA 41-1595629 (State or other jurisdiction of (IRS Employer Identification No.) incorporation)
3905 ANNAPOLIS LANE NORTH, SUITE 105 MINNEAPOLIS, MINNESOTA 55447 (Address of Principal Executive Offices) (763) 553-7736 (Registrant's telephone number, including area code) NOT APPLICABLE (Former name or former address, if changed since last report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below): [ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) [ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) [ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) [ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) ================================================================================ ITEM 2.02 RESULTS OF OPERATIONS AND FINANCIAL CONDITION. On January 25, 2007, ATS Medical, Inc. (the "Company") issued a press release to report preliminary revenue expectations for the fourth quarter and year ended December 31, 2006. The full text of the press release is furnished as Exhibit 99.1 hereto and is incorporated by reference. The information in this current report, including the exhibit thereto, is not deemed "filed" for purposes of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed to be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing. ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS. (c) Exhibits 99.1 Press Release dated January 25, 2007, of ATS Medical, Inc. SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ATS MEDICAL, INC. By: /s/ Michael R. Kramer ------------------------------------ Michael R. Kramer Principal Financial Officer Date: January 29, 2007 EXHIBIT INDEX
Exhibit No. Description - ----------- ------------------------------------------------------------------ 99.1 Press Release, dated January 25, 2007, of ATS Medical, Inc.
EX-99.1 2 c11781exv99w1.txt PRESS RELEASE EXHIBIT 99.1 (ATS MEDICAL LOGO) CONTACTS: Michael Dale, President/CEO Investors: 763-553-7736 Jennifer Beugelmans, 646-201-5447 Michael Kramer, Senior Director of Finance Doug Sherk, 415-896-6820 763-557-2222 Steve DiMattia, 646-201-5445 (Media) ATS MEDICAL PROVIDES PRELIMINARY REVENUE OUTLOOK FOR FOURTH QUARTER AND FULL YEAR 2006 Full Year Revenue Expected to Exceed Guidance of $40 Million MINNEAPOLIS, January 25, 2007 -- ATS Medical, Inc. (NASDAQ: ATSI) manufacturer and marketer of state-of-the-art cardiac surgery products and services, today released preliminary revenue results for the fourth quarter and full year ended December 31, 2006. Total fourth quarter revenue is expected to be approximately $10.6 to $10.8 million compared with $9.9 million in the fourth quarter of 2005. For 2006, ATS Medical expects to report revenue of approximately $40.3 to $40.5 million. Michael Dale, President and CEO said, "When we began the year, our goal was to achieve $40 million in revenue and we are pleased to have surpassed this metric. We believe that the continued successful execution of our diversification strategy will enable us to generate further revenue growth in 2007." ATS Medical plans to issue final results for the fourth quarter and full year 2006 and conduct a conference call after market close during the week of March 5, 2007. At that time the Company will also provide an update on the clinical and regulatory progress of its ATS 3f(R) tissue heart valve products and PARSUS blood filtration development project. ABOUT ATS MEDICAL ATS Medical, Inc. provides innovative products and services focused on cardiac surgery. The company, global in scope, has been headquartered in Minneapolis, Minnesota since its founding in 1991. More than 130,000 ATS Open Pivot(R) Heart Valves, which utilize a unique pivot design resulting in exceptional performance and low risk profile, have been implanted in patients worldwide. The ATS 3F(R) brand encompasses multiple tissue heart valve product offerings at varying steps from market introductions to clinical trials to development projects that incorporate less invasive valve replacement technology. ATS Medical's focus on cardiac surgery is further strengthened by offerings that include ATS Simulus(TM) annuloplasty products for heart valve repair, SurgiFrost(R) and FrostByte(TM) products for surgical cryoablation of cardiac arrhythmias, RTI-Cardiovascular for allograft tissue services, and the development of PARSUS blood filtration technology. The ATS Medical web site is http://www.atsmedical.com. SAFE HARBOR This Press Release contains forward-looking statements that may include statements regarding intent, belief or current expectations of the Company and its management. Actual results could differ materially from those projected in the forward looking statements as a result of a number of important factors, including the results of clinical trials, the integration of 3F Therapeutics, regulatory actions, competition, pricing pressures, supplier actions and management of growth. For a discussion of these and other risks and uncertainties that could affect the Company's activities and results, please refer to the Company's filings with the Securities and Exchange Commission including its Form 10-K for the year ended December 31, 2005, as amended, and its Form S-4 Registration Statement, as amended, filed with respect to the merger with 3F Therapeutics. ### -----END PRIVACY-ENHANCED MESSAGE-----